NCT05907330: An ongoing trial by Curacle Co., Ltd.
This trial is ongoing. It must report results 10 months, 3 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05907330 |
|---|---|
| Title | A Randomized, Double-blind, Placebo-controlled, Multi-center, Phase 2 Study to Evaluate the Efficacy and Safety of CU104 in Patients With Moderate to Severe Ulcerative Colitis |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 1, 2024 |
| Completion date | Feb. 28, 2026 |
| Required reporting date | Feb. 28, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 30, 2026 |
| Days late | None |